Seventy-six consecutive cases of IOGEL intraocular lens implants.
A single piece hydrogel IOGEL (poly-HEMA) intraocular lens was implanted in 76 eyes. Patients obtained a visual acuity of 20/40 or better in 86.9% of cases and a best case visual acuity of 20/40 or better in 98.5% of cases. Patients were followed an average of 12 months (four to 19 months). Two lenses were exchanged with poly(methyl methacrylate) lenses because of decentration-induced glare. Cystoid macular edema occurred in two cases, resulting in visual acuity worse than 20/40 in one case. Results of the study at one year mean follow-up indicate the safety and efficacy of the IOGEL lens as an intraocular implant.
Keates
R H
RH
Corneal Service, Ohio State University, Columbus.
Erdey
R A
RA
Ringel
D M
DM
Schild
H S
HS
D000368:Aged; D011232:Chemical Precipitation; D005260:Female; D006801:Humans; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D007908:Lens, Crystalline / Q000378:metabolism; D007910:Lenses, Intraocular; D008269:Macular Edema / Q000209:etiology; D008297:Male; D010860:Pigments, Biological / Q000378:metabolism; D011092:Polyethylene Glycols; D011183:Postoperative Complications; D014792:Visual Acuity
D010860:Pigments, Biological; D020136:Hydrogel, Polyethylene Glycol Dimethacrylate; D011092:Polyethylene Glycols